The end of the road for OP-1, Olympus shuts down its Biotech Division

Olympus Corporation Announces Plans To Discontinue Operations For Its Biotechnology Division In The U.S. (press release)
Read all stories regarding the OP-1 saga
Olympus Corporation announced today that it plans to discontinue operations for its U.S. biotechnology division, Olympus Biotech.
The company expects the entire closure process to take some time to complete and it will start with the Hopkinton, MA facility.  Commercial operations and product availability will end May 30, 2014 in the United States and Canada.
"This was a very difficult decision and was made only after numerous alternat...